ASCO has joined a coalition of more than a dozen specialty societies in supporting an effort in the U.S. House of Representatives to relieve the significant administrative burdens and financial penalties slated to be imposed on physicians in 2018 as part of the Medicare physician fee schedule (MPFS)—due to be released this summer. ASCO is concerned about the impact these burdens could have on patient care since oncologists would have to juggle the requirements of multiple Medicare quality improvement programs in addition to time spent providing patient care.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
ASCO recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to the agency’s call for stakeholder input on measuring and comparing oncologists and other health care providers based on cost under the Quality Payment Program’s (QPP) Merit-Based Incentive Payment System (MIPS).
This year, oncology practices across the country are implementing changes to comply with the Quality Payment Program (QPP), established by the Medicare Access and CHIP Reauthorization Act (MACRA), which will transition practices from the current fee-for-service reimbursement system to providing value-based cancer care.
ASCO recently joined more than 180 patient and provider advocacy groups in signing a letter to the Medicare Payment Advisory Commission (MedPAC), urging the congressional advisory group to reconsider proposed changes to Medicare Part B drug reimbursement.
The Quality Payment Program (QPP), established by the Medicare Access and CHIP Reauthorization Act, launched in January 2017 and is being implemented in oncology practices across the country. 2017 is a transition year, but practices still have to report some quality data in order to avoid financial penalties in 2019. This transition year offers practices an opportunity to test the QPP reporting system before 2018, when quality reporting will require a significantly heavier lift to avoid financial penalties in 2020. ASCO is releasing a series of webinars to guide oncology practices to successful quality reporting.
The deadline to submit reconsideration applications for the 2017 Electronic Health Record (EHR) Incentive Program payment adjustment—based on the 2015 reporting period—is Feb. 28, 2017. Applications will not be accepted after the deadline.
The Centers for Medicare & Medicaid Services (CMS) has extended the attestation deadline for the 2016 Medicare EHR Incentive Program to Monday, March 13, 2017, at 11:59 p.m. PT. Participating providers must attest to the 2016 program requirements before the deadline to avoid a negative payment adjustment in 2018.
With the new Congress and Administration in place, ASCO has been on Capitol Hill monitoring the issues that affect the cancer care community, and educating lawmakers on how best to serve Americans with cancer. In particular, ASCO is closely tracking efforts to repeal and replace the Affordable Care Act (ACA), the discussion on the future of Medicaid, and relevant cabinet appointments.